Success Metrics

Clinical Success Rate

100.0%

Based on 1 completed trials

Completion Rate

100%(1/1)

Active Trials

0(0%)

Results Posted

0%(0 trials)

Phase Distribution

Ph not_applicable

100%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution3 total trials

N/ANon-phased studies

3(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(1)

Completed(1)

Other(1)

Detailed Status

Not yet recruiting1

unknown1

Completed1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

N/A

Trials by Phase

N/A3 (100.0%)

Trials by Status

not_yet_recruiting133%

unknown133%

completed133%

Recent Activity

0 active trials

Showing 3 of 3

not_yet_recruitingnot_applicable

ESP vs. EXORA Blocks for Analgesia in Laparoscopic Cholecystectomy

NCT06900413

completednot_applicable

Anesthesia for Percutaneous Kyphoplasty

NCT07091513

unknownnot_applicable

ESP Block on Patient Outcomes in Patients With Liver Tumor Undergoing Radiofrequency Ablation

NCT05009550

Clinical Trials (3)

Showing 3 of 3 trials

NCT06900413Not Applicable

ESP vs. EXORA Blocks for Analgesia in Laparoscopic Cholecystectomy

Not Yet Recruiting

NCT07091513Not Applicable

Anesthesia for Percutaneous Kyphoplasty

Completed

NCT05009550Not Applicable

ESP Block on Patient Outcomes in Patients With Liver Tumor Undergoing Radiofrequency Ablation

Unknown

All 3 trials loaded

Drug Details

Intervention Type: PROCEDURE
Total Trials: 3